Tag: NLY01
-
D&D Pharmatech Partners with LG AI Research Institute to Accelerate Oral Peptide New Drug Development
Recent news has drawn significant attention from the bio-industry. D&D Pharmatech, an innovative new drug development biotech company, has signed a definitive agreement with LG AI Research Institute to jointly develop next-generation AI-based peptide new drugs. This is interpreted as a strategic move to gain leadership in the global new drug market through the convergence…